Institute receives Platinum Green Impact Award for 2020/21
The Cancer Research UK Cambridge Institute has achieved Platinum in the University’s Green Impact Awards.
Green Impact is the University of Cambridge’s environmental accreditation scheme. It supports and encourages departments and colleges across the University in reducing their environmental impacts.
With support from the Environment and Energy Section, departments can form a small team, who sign up to an online workbook and progress through simple, clear and easy criteria towards recognised awards and targets.
Over the last year, our Green Impact team has been working hard to implement new green initiatives within the building, including green procurement agreements, supporting biodiversity onsite, introducing new recycling systems, and creating a pledge programme for staff. Many thanks to the team members: Grace Davison, Cathy Pauley, Emma Wright, Chloe Cashman, Amy Cullen, Beverly Bernhardt, Allan Lui and Colin Weir.
The auditor said “The team has done excellent work in embedding sustainability across the department. The actions taken were well planned and clearly communicated, with evidence of enthusiastic participation from the department. Well done everyone!”
The Institute continues to be fully committed to reducing our impact on the environment wherever possible.
Related News
See all news-
Sir Shankar Balasubramanian elected Fellow of the AACR Academy
10th March 2025
Sir Shankar has been recognised for his pioneering research in nucleic acid chemistry and his key role in the development of next-generation sequencing technology.
Find out more -
Richard Mair joins Institute as an Independent Clinical Fellow
10th February 2025
Richard will build a research group at the Institute to focus on IDH mutant astrocytoma, , a common type of brain tumour that accounts for 9% of brain tumour diagnoses.
Find out more -
Imaging technique allows rapid assessment of ovarian cancer subtypes and their response to treatment
6th December 2024
An MRI-based imaging technique developed at the Institute predicts the response of ovarian cancer tumours to treatment, and rapidly reveals how well treatment is working, in patient-derived cell models.
Find out more